{"name": "Phico Therapeutics",
 "permalink": "phico-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/phico-therapeutics",
 "homepage_url": "http://www.phicotherapeutics.co.uk",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@phicotherapeutics.co.uk",
 "phone_number": "44-(0)1223-496755",
 "description": "",
 "created_at": "Wed Apr 28 11:02:59 UTC 2010",
 "updated_at": "Wed Jun 15 00:25:11 UTC 2011",
 "overview": "\u003Cp\u003EPhico Therapeutics is developing a unique antibiotic technology to address one the most urgent challenges facing medicine today \u00e2\u20ac\u201c how to destroy multi-drug resistant bacteria, the so-called \u00e2\u20ac\u0153superbugs\u00e2\u20ac\u009d.\u003C/p\u003E\n\n\u003Cp\u003EPhico\u00e2\u20ac\u2122s patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. SASPject\u00e2\u201e\u00a2 is a new class of antibiotic which could provide many advantages over conventional antibiotic classes.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       82],
      "assets/images/resized/0008/5184/85184v1-max-150x150.jpg"],
     [[193,
       106],
      "assets/images/resized/0008/5184/85184v1-max-250x250.jpg"],
     [[193,
       106],
      "assets/images/resized/0008/5184/85184v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a31M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.businessweekly.co.uk/biomedtech-/12006-cambridge-biotech-raises-p1m-to-develop-e-coli-fighting-agent",
    "source_description": "Investors show support of Phico Therapeutics by upping stake by \u00c2\u00a31m",
    "raised_amount": 1000000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2011,
    "funded_month": 6,
    "funded_day": 11,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Babraham Research Campus",
    "address2": "Babraham",
    "zip_code": "CB22 3AT",
    "city": "Cambridge",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Phico Therapeutics today announces the successful completion of a phase I trial showing that their new antibiotic, SASPject PT1.2 is safe and well tolerated in healthy human volunteers. Plans for a phase II trial to assess efficacy are already underway.",
    "stoned_year": 2010,
    "stoned_month": 6,
    "stoned_day": 17,
    "source_url": "http://www.wellcome.ac.uk/News/2010/News/WTX059625.htm",
    "source_text": null,
    "source_description": "Wellcome Trust Award-Winning Company Phico Therapeutics Announces Success of Safety and Tolerability Trial",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Phico Therapeutics",
      "permalink": "phico-therapeutics"}},
   {"description": "Phico Therapeutics announces Dr Anthony F. Martin as Board Chairman",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 26,
    "source_url": "http://www.phicotherapeutics.co.uk/news012.html",
    "source_text": null,
    "source_description": "As SASPject enters phase II Phico Therapeutics announces Dr Anthony F. Martin as Board Chairman",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Phico Therapeutics",
      "permalink": "phico-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        98],
       "assets/images/resized/0008/5185/85185v1-max-150x150.jpg"],
      [[250,
        163],
       "assets/images/resized/0008/5185/85185v1-max-250x250.jpg"],
      [[450,
        294],
       "assets/images/resized/0008/5185/85185v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}